1. Home
  2. CANF vs LMFA Comparison

CANF vs LMFA Comparison

Compare CANF & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.45

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Logo LM Funding America Inc.

LMFA

LM Funding America Inc.

HOLD

Current Price

$0.23

Market Cap

5.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANF
LMFA
Founded
1994
2008
Country
Israel
United States
Employees
N/A
19
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.6M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
CANF
LMFA
Price
$3.45
$0.23
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$50.00
$5.00
AVG Volume (30 Days)
938.6K
306.3K
Earning Date
03-26-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.66
EPS
N/A
N/A
Revenue
N/A
$8,844,733.00
Revenue This Year
$2,715,455.50
$4.38
Revenue Next Year
$101.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.18
52 Week High
$10.40
$5.14

Technical Indicators

Market Signals
Indicator
CANF
LMFA
Relative Strength Index (RSI) 56.46 39.40
Support Level $2.89 $0.22
Resistance Level $4.74 $0.32
Average True Range (ATR) 0.35 0.02
MACD 0.09 0.00
Stochastic Oscillator 52.80 13.75

Price Performance

Historical Comparison
CANF
LMFA

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: